Moderna is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology. Moderna designs mRNA molecules that instruct cells to produce specific proteins, with applications in the prevention and treatment of a range of diseases. Its research and development activities span infectious diseases, cancer, rare diseases, autoimmune conditions, and other therapeutic areas. Moderna maintains a pipeline of vaccine and therapeutic candidates and utilizes a platform approach that combines mRNA design, delivery technologies, and manufacturing processes across multiple programs. The company also collaborates with research institutions, healthcare organizations, and industry partners for the development of its mRNA-based medicines.